WCN24-1077 NOVEL BIOMARKERS AND PREDICTION OF KIDNEY DISEASE PROGRESSION IN AUSTRALIAN FIRST NATION PEOPLE WITH AND WITHOUT DIABETES: THE eGFR STUDY

WCN24-1077 NOVEL BIOMARKERS AND PREDICTION OF KIDNEY DISEASE PROGRESSION IN AUSTRALIAN FIRST NATION PEOPLE WITH AND WITHOUT DIABETES: THE eGFR STUDY

Saved in:

Bibliographic Details
Main Authors:	Richard MacIsaac, Elizabeth Barr, Federica Barzi, Phillip Mills, Maria Nickels, Sian Graham, Varuni Obeyesekere, Wendy Hoy, Graham Jones, Paul Lawton, Alex Brown, Mark Thomas, Ashim Sinha, Alan Cass, Jaquelyne Hughes, Louise Maple-Brown
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924003267
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort Study
by: Elizabeth L. M. Barr, et al.
Published: (2025-08-01)

Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis
by: Sandawana William Majoni, et al.
Published: (2017-01-01)

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes
by: Haihui Li, et al.
Published: (2024-10-01)

eGFR slope as predictor of mortality in heart failure patients
by: Sofie Verstreken, et al.
Published: (2025-04-01)

Evaluation of race-free eGFR equations in individuals of different ethnicity
by: De-Wei An, et al.
Published: (2025-12-01)

Feasibility of replacing 99mTc‐DTPA GFR measurements with eGFR from cystatin C in individuals with spinal cord injuries
by: Tatiana Kristensen, et al.
Published: (2025-05-01)

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.
by: Carsten A Böger, et al.
Published: (2011-09-01)

WCN25-405 eGFR Trajectories in Iraqi Cancer Patients at First Presentation
by: Ala Ali, et al.
Published: (2025-02-01)

Disease Progression Modeling of Estimated Glomerular Filtration Rate (eGFR): A Pharmacometrics Approach
by: Sohail Aziz, et al.
Published: (2025-06-01)

The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism
by: Jing Xu, et al.
Published: (2020-01-01)

Joint effects of elevated homocysteine levels and low eGFR on post-stroke cognitive impairment
by: Chunyan Zhang, et al.
Published: (2025-08-01)

Renal Function and Death in Older Women: Which eGFR Formula Should We Use?
by: Muna T. Canales, et al.
Published: (2017-01-01)

Urinary Proteomic Shifts over Time and Their Associations with eGFR Decline in Chronic Kidney Disease
by: Zhalaliddin Makhammajanov, et al.
Published: (2025-01-01)

Evaluation of serum Cystatin C as a predictor of eGFR in type 2 diabetic patients with nephropathy
by: Aqsa Fatima, et al.
Published: (2025-06-01)

Association of baseline eGFR and incident heart failure on patients receiving intensive blood pressure treatment
by: Li Haonan, et al.
Published: (2025-06-01)

Comment on: Association of eGFR with stages of diabetic retinopathy and age-related macular degeneration in Indian population
by: Rui Yao, et al.
Published: (2025-01-01)

Associations of serum uric acid to eGFR ratio with diabetic retinopathy in individuals with type 2 diabetes
by: Chenyu Nie, et al.
Published: (2025-05-01)

Longitudinal Trajectories of Albuminuria and eGFR in Type 2 Diabetes Mellitus: Natural Progression of Diabetic Kidney Disease
by: Xiuqi Qiao, et al.
Published: (2025-01-01)

Estimated Glomerular Filtration Rate (eGFR) as an In-Hospital Mortality Predictor in Acute Coronary Syndrome Patients in ICCU
by: Esthika Dewiasty, et al.
Published: (2016-12-01)

Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE)
by: Antonio Bernabe-Ortiz, et al.
Published: (2019-09-01)

Author's Response to comment on: Association of eGFR with stages of diabetic retinopathy and age-related macular degeneration in an Indian population
by: Vidya Neelamegam, et al.
Published: (2025-01-01)

WCN25-2085 COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN FOR CHRONIC KIDNEY DISEASE BASED ON eGFR- AND ALBUMINURIA-BASED SUBGROUPS
by: Motoki Odawara, et al.
Published: (2025-02-01)

Association between urinary heavy metals and cardiovascular-kidney-metabolic syndrome: mediating roles of TyG, WWI, and eGFR
by: Jianping Liu, et al.
Published: (2025-06-01)

Association of Difference Between eGFR From Cystatin C and Creatinine and Serum GDF‐15 With Adverse Outcomes in Diabetes Mellitus
by: Tomohito Gohda, et al.
Published: (2025-08-01)

Utility of the combination of IVIM-DWI MRI and baseline eGFR for identifying a high risk of chronic kidney disease progression
by: Yazhen Yu, et al.
Published: (2025-02-01)

Correlation Between Neutrophil to Lymphocyte Ratio and eGFR in Diabetic Patients: A Cross-sectional Analysis Based on NHANES Data
by: JIA Chunyu, et al.
Published: (2025-01-01)

Association between serum uric acid variability and mild eGFR decline in Chinese adults: a retrospective cohort study
by: Na Li, et al.
Published: (2024-10-01)

Comparation of two cystatin C-based eGFR equations in assessing risk of all-cause mortality and incident cardiovascular disease
by: Guangda Xin, et al.
Published: (2024-11-01)

Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol
by: Louise Maple-Brown, et al.
Published: (2022-12-01)

Is eGFR Slope a Novel Predictor of Chronic Complications of Type 2 Diabetes Mellitus? A Systematic Review and Meta-Analysis
by: Giovanni Sartore, et al.
Published: (2024-01-01)

Ethnic differences in CKD progression among people with type 2 diabetes and rapid eGFR decline: A secondary data analysis
by: Thamer Alobaid, et al.
Published: (2025-07-01)

Perinephric fat volume and its negative correlation with the eGFR according to a population health screening: a cross-sectional study
by: Xiaohui Zhang, et al.
Published: (2025-12-01)

WCN25-2491 COMPARATIVE EVALUATION OF eGFR EQUATIONS FOR RENAL FUNCTION ASSESSMENT IN PREGNANT WOMEN: A CROSS-SECTIONAL STUDY IN VIETNAM
by: Hoang Nguyen Huy Ho, et al.
Published: (2025-02-01)

WCN25-629 LONG-TERM RISK OF ESKD IN KIDNEY DONORS WITH DIABETES MELLITUS USING eGFR AT 6 MONTHS POST-DONATION
by: Lovy Gaur, et al.
Published: (2025-02-01)

SARS-CoV-2 Infection Is Associated with an Accelerated eGFR Decline in Kidney Transplant Recipients up to Four Years Post Infection
by: Shawn Qiu, et al.
Published: (2025-04-01)

Comparing Cystatin C Estimated GFR With Creatinine Estimated GFR in Acute Kidney Injury Recovery
by: Kerry L. Horne, et al.
Published: (2025-08-01)

Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS
by: Caitlin S. Brown, et al.
Published: (2016-01-01)

WCN24-1427 Epidemiology of kidney disease in patients without health insurance in a Latin American city. Who develop accelerated deterioration of eGFR
by: Diego Argudo, et al.
Published: (2024-04-01)

Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
by: Chuchu Zeng, et al.
Published: (2017-01-01)

WCN25-1898 IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT
by: Bruce Hendry, et al.
Published: (2025-02-01)